![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: WTIP |
Gene summary for WTIP |
![]() |
Gene information | Species | Human | Gene symbol | WTIP | Gene ID | 126374 |
Gene name | WT1 interacting protein | |
Gene Alias | WTIP | |
Cytomap | 19q13.11 | |
Gene Type | protein-coding | GO ID | GO:0000902 | UniProtAcc | A6NIX2 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
126374 | WTIP | male-WTA | Human | Thyroid | PTC | 3.94e-14 | 2.25e-01 | 0.1037 |
126374 | WTIP | PTC01 | Human | Thyroid | PTC | 3.00e-08 | 1.69e-01 | 0.1899 |
126374 | WTIP | PTC03 | Human | Thyroid | PTC | 1.79e-02 | 1.58e-01 | 0.1784 |
126374 | WTIP | PTC04 | Human | Thyroid | PTC | 5.21e-17 | 3.73e-01 | 0.1927 |
126374 | WTIP | PTC05 | Human | Thyroid | PTC | 1.04e-21 | 6.44e-01 | 0.2065 |
126374 | WTIP | PTC06 | Human | Thyroid | PTC | 3.49e-37 | 7.83e-01 | 0.2057 |
126374 | WTIP | PTC07 | Human | Thyroid | PTC | 2.12e-37 | 6.45e-01 | 0.2044 |
126374 | WTIP | ATC12 | Human | Thyroid | ATC | 6.97e-05 | 1.36e-01 | 0.34 |
126374 | WTIP | ATC13 | Human | Thyroid | ATC | 5.13e-86 | 1.46e+00 | 0.34 |
126374 | WTIP | ATC2 | Human | Thyroid | ATC | 1.24e-20 | 1.14e+00 | 0.34 |
126374 | WTIP | ATC3 | Human | Thyroid | ATC | 6.22e-03 | 2.27e-01 | 0.338 |
126374 | WTIP | ATC4 | Human | Thyroid | ATC | 1.06e-08 | 1.84e-01 | 0.34 |
126374 | WTIP | ATC5 | Human | Thyroid | ATC | 6.30e-83 | 1.53e+00 | 0.34 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Thyroid | ![]() | ATC: Anaplastic thyroid cancer |
HT: Hashimoto's thyroiditis | ||
PTC: Papillary thyroid cancer |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:003532921 | Thyroid | ATC | hippo signaling | 24/6293 | 40/18723 | 5.54e-04 | 3.20e-03 | 24 |
GO:006096815 | Thyroid | ATC | regulation of gene silencing | 38/6293 | 81/18723 | 8.77e-03 | 3.33e-02 | 38 |
Page: 1 2 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
WTIP | SNV | Missense_Mutation | c.895N>A | p.Glu299Lys | p.E299K | A6NIX2 | protein_coding | deleterious(0.01) | possibly_damaging(0.9) | TCGA-E2-A1LG-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicin | SD | |
WTIP | SNV | Missense_Mutation | c.1208N>A | p.Gly403Asp | p.G403D | A6NIX2 | protein_coding | tolerated(0.5) | possibly_damaging(0.842) | TCGA-EW-A1IZ-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | taxotere | SD | |
WTIP | SNV | Missense_Mutation | novel | c.1012T>C | p.Cys338Arg | p.C338R | A6NIX2 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-5M-AAT6-01 | Colorectum | colon adenocarcinoma | Female | <65 | III/IV | Unknown | Unknown | PD |
WTIP | SNV | Missense_Mutation | rs370840550 | c.782N>A | p.Arg261His | p.R261H | A6NIX2 | protein_coding | deleterious(0) | probably_damaging(0.993) | TCGA-WS-AB45-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
WTIP | SNV | Missense_Mutation | novel | c.868T>G | p.Cys290Gly | p.C290G | A6NIX2 | protein_coding | deleterious(0) | probably_damaging(0.992) | TCGA-F5-6814-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
WTIP | SNV | Missense_Mutation | novel | c.818A>T | p.Tyr273Phe | p.Y273F | A6NIX2 | protein_coding | tolerated(0.46) | possibly_damaging(0.549) | TCGA-AP-A054-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatin | PD |
WTIP | SNV | Missense_Mutation | novel | c.778N>T | p.Leu260Phe | p.L260F | A6NIX2 | protein_coding | deleterious(0) | probably_damaging(0.954) | TCGA-AP-A059-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
WTIP | SNV | Missense_Mutation | c.1184N>T | p.Gly395Val | p.G395V | A6NIX2 | protein_coding | deleterious(0) | probably_damaging(0.971) | TCGA-AX-A1C7-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Chemotherapy | topotecan | SD | |
WTIP | SNV | Missense_Mutation | novel | c.802G>A | p.Val268Met | p.V268M | A6NIX2 | protein_coding | deleterious(0.03) | probably_damaging(0.986) | TCGA-B5-A11U-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
WTIP | SNV | Missense_Mutation | c.1208N>A | p.Gly403Asp | p.G403D | A6NIX2 | protein_coding | tolerated(0.5) | possibly_damaging(0.842) | TCGA-DI-A1BU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | paclitaxel | SD |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |